NASDAQ · Financial Statements

Omada Health, Inc. (OMDA) Revenue, Earnings & Financial Statements

$14.08 NASDAQ: OMDA Market Cap $873.49M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Omada Health, Inc. most recently reported annual revenue of $260.0M, a net loss of $13.0M. Revenue grew at an average annual rate of 43.0% over the last 3 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Omada Health, Inc.: Revenue rose from $89.0M in 2022 to $260.0M in 2025, a change of +192.1% over 3 years; net profit was positive in 0 of 4 reported years; operating margin moved from -81.1% to -4.6%, a shift of +76.5 percentage points; the most recent year shows a net loss of $13.0M.

Income Statement — 4 Years (USD millions)

Metric2022202320242025
Revenue$89.0M$123.0M$170.0M$260.0M
Operating Expenses$162.0M$189.0M$213.0M$272.0M
Operating Profit−$72.0M−$66.0M−$44.0M−$12.0M
Operating Margin-81.1%-53.8%-25.7%-4.6%
Other Income$0−$2.0M−$3.0M−$1.0M
Interest$4.0M$5.0M$5.0M$3.0M
Depreciation$4.0M$4.0M$5.0M$5.0M
Profit Before Tax−$73.0M−$68.0M−$47.0M−$13.0M
Tax rate (%)0.0%0.0%0.0%0.0%
Net Profit−$73.0M−$68.0M−$47.0M−$13.0M
EPS−$1.30−$1.21−$0.85−$0.22

Quarterly Results — Last 12 Quarters (USD millions)

1 duplicate period label in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$33.0M$35.0M$41.0M$46.0M$48.0M$55.0M$61.0M$68.0M$76.0M$78.0M$88.0M$91.0M
Operating Expenses$46.0M$53.0M$51.0M$54.0M$55.0M$63.0M$66.0M$71.0M$73.0M$83.0M$84.0M$86.0M
Operating Profit−$13.0M−$18.0M−$10.0M−$9.0M−$7.0M−$8.0M−$4.0M−$3.0M$3.0M−$5.0M$4.0M$5.0M
Operating Margin-41.2%-51.3%-24.4%-18.7%-14.8%-15.3%-7.1%-3.7%4.3%-6.1%4.0%5.3%
Interest$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M$0$0$0$0$0
Profit Before Tax−$14.0M−$19.0M−$11.0M−$9.0M−$8.0M−$9.0M−$5.0M−$3.0M$5.0M−$3.0M$5.0M$7.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$14.0M−$19.0M−$11.0M−$9.0M−$8.0M−$9.0M−$5.0M−$3.0M$5.0M−$3.0M$5.0M−$2.0M
EPS−$0.25−$0.34−$0.19−$0.17−$0.15−$0.17−$0.09−$0.05$0.09−$0.05$0.08−$0.04

Over the 4 years reported for Omada Health, Inc., borrowings decreased from $31.0M in 2022 to $0 in 2025, cash stood at $222.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.59 times.

Balance Sheet — 4 Years (USD millions)

Metric2022202320242025
Total Assets$222.0M$175.0M$151.0M$305.0M
Current Assets$189.0M$143.0M$113.0M$273.0M
Cash$168.0M$116.0M$76.0M$222.0M
Inventory$4.0M$4.0M$3.0M$4.0M
Receivables$12.0M$16.0M$24.0M$35.0M
Fixed Assets$6.0M$6.0M$6.0M$8.0M
Capital Work in Progress$0$0$0$0
Investments$0$0$0$0
Other Assets$13.0M$13.0M$13.0M$13.0M
Total Liabilities$66.0M$76.0M$86.0M$76.0M
Current Liabilities$35.0M$44.0M$54.0M$76.0M
Borrowings$31.0M$31.0M$30.0M$0
Other Liabilities$35.0M$46.0M$56.0M$76.0M
Equity$0$0$0$0
Reserves$156.0M$99.0M$65.0M$230.0M

For Omada Health, Inc., operating cash flow was positive in 1 of 4 reported years; free cash flow in the latest year was $17.0M; free cash flow was positive in 1 of 4 years; financing activities used $6.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 4 Years (USD millions)

Metric2022202320242025
Operating Cash Flow−$69.0M−$50.0M−$34.0M$18.0M
Investing Cash Flow−$5.0M−$6.0M−$8.0M−$7.0M
Financing Cash Flow$1.0M−$3.0M−$5.0M−$6.0M
Net Cash Flow−$55.0M−$52.0M−$39.0M$146.0M
Free Cash Flow−$72.0M−$53.0M−$38.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.92
EV / EBITDA90.28
FCF Yield1.89%
Quick Ratio3.54
Interest Coverage-4.00
Return 1Y-27.65%
Return 3Y—
Return 5Y—

Omada Health, Inc. (OMDA) financials — frequently asked questions

What is Omada Health, Inc.'s annual revenue?

Omada Health, Inc. (OMDA) reported annual revenue of $260.0M in its most recent fiscal year.

What is Omada Health, Inc.'s net profit?

Omada Health, Inc. (OMDA) reported a net loss of $13.0M in its most recent fiscal year.

What is OMDA EV/EBITDA?

Omada Health, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 90.28.

Revenue and earnings of other Medical - Healthcare Information Services stocks

VEEV revenue $3.2BGEHC revenue $20.6BBTSG revenue $12.9BTEM revenue $1.3BHNGE stockHQY revenue $1.3BDOCS revenue $645.0MHTFL stockPRVA revenue $2.1BCERT revenue $419.0MAll Medical - Healthcare Information Services stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
OMDA Overview OMDA Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.